Efficacy and Safety of ASK120067 (limertinib) in Patients with Locally Advanced or Metastatic EGFR T790M-mutated Non–small Cell Lung Cancer: A Multicenter, Single-Arm, Phase IIb Study.
Journal of Clinical Oncology（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined